Long-term virological outcome and resistance mutations at virological rebound in HIV-infected adults on protease inhibitor-sparing highly active antiretroviral therapy.
about
Preparing for highly active antiretroviral therapy rollout in rural South Africa: an assessment using the information, motivation, and behavioral skills model.Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014-July 2015.Monitoring HIV treatment in developing countries.Predicting resistance as indicator for need to switch from first-line antiretroviral therapy among patients with elevated viral loads: development of a risk score algorithm
P2860
Long-term virological outcome and resistance mutations at virological rebound in HIV-infected adults on protease inhibitor-sparing highly active antiretroviral therapy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Long-term virological outcome ...... active antiretroviral therapy.
@en
type
label
Long-term virological outcome ...... active antiretroviral therapy.
@en
prefLabel
Long-term virological outcome ...... active antiretroviral therapy.
@en
P2093
P50
P356
P1476
Long-term virological outcome ...... active antiretroviral therapy.
@en
P2093
Armando Sánchez-Quijano
Eduardo Lissen
Laura Rivero
Manuel Leal
María Antonia Abad
Miguel Genebat
Rafael de la Rosa
P304
P356
10.1093/JAC/DKH012
P407
P577
2003-12-04T00:00:00Z